TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: VAS scores for postoperative sore throat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hoarseness incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: nausea level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: post-operation exhaust and defecation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Final ED Blood Glucose (BG) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Admission Blood Glucose (BG) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hypoglycemia incidents (BG < 50 mg/dL)
Endpoint domain: Adverse events/effects
Primary endpoint: Breast-associated symptoms reduction
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: FBF responsiveness to vasoconstrictors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Adverse events of bradykinesia and parkinsonian gait
Endpoint domain: Adverse events/effects
Primary endpoint: Presentation to the emergency department for related complications
Endpoint domain: Adverse events/effects
Primary endpoint: Mean visual analog scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participation in care management
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Postoperative temporary hypoparathyroidism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Mean PC20 value after allergen challenge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Increase of BHR after DBPCFC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 3 or more consecutive weeks of abstinence from cocaine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urine specimens negative for all drugs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of hypoxemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pulmonary compliance values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Oxygenation indexes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total sickness absence duration
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Proportion of long-term sickness absence spells (>28 days)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Mean serum lithium levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Equipment contamination rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Cross contamination cases
Endpoint domain: Adverse events/effects
Primary endpoint: microbiological measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mammography screening completion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Fewer cardiac procedures indicative of worsening heart failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in New York Heart Association class
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in Minnesota Living with Heart Failure score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Diurnal IOP reduction at 0800 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Range of diurnal IOP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: 6-keto-PGF1α levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood pressure levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: UVA evaluation scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GEARS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NASA TLX temporal demand and effort
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Postprandial glucose fluctuations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PC20FEV1 after FK-224 vs placebo
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Improvement of PCOS clinical and biochemical abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of ovarian dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: tissue performance improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delay in airway reflex recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of ART restorations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of fall
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of inflamed lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: booster seat use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression to active labour
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Vaginal delivery within 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Concentric muscle quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eccentric muscle quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction of pulse pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Postoperative pain relief (OPS scores)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Requirement for postoperative supplementary analgesic
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Migraine intensity reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Migraine frequency reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Migraine lasting time reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in depressed mood
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: early recanalization 1.5 hour after tPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: central blood pressure parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in hunger
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of CI-AKI
Endpoint domain: Adverse events/effects
Primary endpoint: Barium discharging rate (%) at 48 h and 72 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Risk reduction of second breast cancer
Endpoint domain: Mortality/survival
Primary endpoint: job satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Improvement in psychogenic erectile function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reported severity of symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Resolution of symptoms rated moderately bad or worse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneal Endothelial Cell Density (CECD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time to reach full anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time to regain full sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean block duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in serum global lipid profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease in number and intensity of hot flushes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: alleviation of sleep disturbances
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: reduction of fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: overall survival at three years
Endpoint domain: Mortality/survival
Primary endpoint: median time to progression of the disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trust in care received
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient safety criteria fulfillment
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of liver cancer
Endpoint domain: Mortality/survival
Primary endpoint: Colonization rate of staphylococci in the intestine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: local recurrence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3-, 5-, and 7-year survival rates
Endpoint domain: Mortality/survival
Primary endpoint: Cost per person counseled
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cost per positive mutation detected
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Pharmacist time spent on anticoagulation counseling
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Endothelial cell colony-forming units count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: depression change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained oxycodone analgesic concentration duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart rate averages
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improved test-retest reliability (ICC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satiety area under the curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean endoscopy score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: olfaction score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean percentage of labeled concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in wheezing and total RDAI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Persistence of respiratory symptoms post-discharge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Serum aminotransferase levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Grading scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3-year change in mean maximum intimal-medial thickness of the carotid arteries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Actuarial survival at 6, 12, and 24 months
Endpoint domain: Mortality/survival
Primary endpoint: Tumor size at 2 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pharyngeal swallowing function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: extra medication needed
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduction in severity of bulimic symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KSS clinical and KSS function scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total nerve length
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: total number of nerves
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: number of main nerve trunks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mean ventilation volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ability to compress with adequate depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DeltaGFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: RBC viability at 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Grade ≥ II leukopenia
Endpoint domain: Adverse events/effects
Primary endpoint: Grade ≥ II neutropenia
Endpoint domain: Adverse events/effects
Primary endpoint: Comfort before IOL insertion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Routine classification of IOL insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: cue-induced craving relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postocclusive endothelium‐dependent hyperemic reaction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average scores of visual analogue scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: overall operative morbidity
Endpoint domain: Adverse events/effects
Primary endpoint: Need for systemic therapy with aminophylline or steroids
Endpoint domain: Adverse events/effects
Primary endpoint: Bronchodilator reversibility (BDR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: COPD assessment test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Kt/Vurea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean daily sodium removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: decreased risk of developing at least 1 infection
Endpoint domain: Adverse events/effects
Primary endpoint: total number of infections
Endpoint domain: Adverse events/effects
Primary endpoint: Decrease in HBV DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: asthma quality of life (physical domain)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: asthma quality of life (social activity domain)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: asthma self-management knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence of abnormal glucose tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Severity of global psychopathology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage diameter stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of insufficient compressions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: correct hand position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median tooth shade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: utilization time for sensory, motor, and pain-tolerance thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mother-to-child transmission of HIV
Endpoint domain: Mortality/survival
Primary endpoint: successful outcome without complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complete aesthetic satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: improvement in phonation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health care utilisation
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Quality of physician-patient interaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient treatment satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of loss of bone at the femoral neck
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Nasal trauma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: freedom from angina
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Undergoing conventional prostate cancer treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: PSA level >or=10 ng/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSA velocity >2 ng/mL/y
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reproducibility of nerve fiber layer thickness measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean pancreatic enhancement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Optimal pancreatic enhancement index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to peak enhancement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WOMAC function subscale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 10-cm VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean absolute CD4 count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of primary care visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: hernia recurrence at 2 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: overall rate of postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Effectiveness of montelukast in treating EIB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Frequency of respiratory clinical adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Role limitations due to health problems
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Substantial improvements in mean changes of SMWD from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Improved average walking speed from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Relief from knee pain after physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Cardiac Output (CO) estimates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Systemic Vascular Resistance (SVR) estimates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: serum bicarbonate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 24-h urine volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: site-specific pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: estimated blood alcohol concentration (eBAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of weekly drinks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-management
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Survival rate at day 28
Endpoint domain: Mortality/survival
Primary endpoint: Requirement for norepinephrine, epinephrine, and dopamine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global VAS pain scores with activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bladder spasm pain occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Composite outcome of CV death, myocardial infarction, stroke, or hospitalization for unstable angina
Endpoint domain: Mortality/survival
Primary endpoint: early biochemical relapse
Endpoint domain: Mortality/survival
Primary endpoint: clinical disease-free survival
Endpoint domain: Mortality/survival
Primary endpoint: metastatic failure rate
Endpoint domain: Mortality/survival
Primary endpoint: Composite of death, myocardial infarction, or urgent repeat revascularization
Endpoint domain: Mortality/survival
Primary endpoint: Maternal milk production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protein nitrogen fraction of human milk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum levels of atherogenic lipids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: BMI at 1 year postpartum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes